Clinical trial

A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine

NCT04975035

Study summary

ClinicalTrials.gov

A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1, PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Zolodine Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2012-01-01

PhasePHASE1 / PHASE2

Conditions

Schizophreniaverified · MONDO: schizophrenia

Interventions

ZolodineDRUG

Sponsors & collaborators

Second Affiliated Hospital, Zhejiang University, School of Medicinelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04975035 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.